Misty Humphries

Dr. Misty Humphries


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MHMisty Humphries
Misty Humphries
EAEhrin Armstrong
Ehrin Armstrong
JLJohn Laird
John Laird
JPJessica Paz
Jessica Paz
WPWilliam Pevec
William Pevec

1 December 2016 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MHMisty Humphries
Misty Humphries
ABAnn Brunson
Ann Brunson
CLChin-Shang Li
Chin-Shang Li
JMJoy Melnikow
Joy Melnikow
PRPatrick S. Romano
Patrick S. Romano

1 January 2016 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
MHMisty Humphries
Misty Humphries
ABAnn Brunson
Ann Brunson
NHNasim Hedayati
Nasim Hedayati
PRPatrick Romano
Patrick Romano
JMJoy Melnkow
Joy Melnkow

1 August 2021 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MHMisty Humphries
Misty Humphries
AMAngelina Mikityuk
Angelina Mikityuk
LHLinda Harris
Linda Harris
JSJessica P. Simons
Jessica P. Simons
BABernadette Aulivola
Bernadette Aulivola
ARAmy B. Reed
Amy B. Reed

2 November 2023 in Journal of Vascular Surgery Cases, Innovations and Techniques
Verified
Journal Article
Open access
KDKathryn DiLosa
Kathryn DiLosa
CPCara Pozolo
Cara Pozolo
THThomas Heafner
Thomas Heafner
MHMisty Humphries
Misty Humphries
MKMimmie Kwong
Mimmie Kwong
SMSteven Maximus
Steven Maximus
The Gore TAG thoracic branch endoprosthesis (TBE) is the first Food and Drug Administration–approved device for zone 2 thoracic endovascular aortic repair, allowing for graft placement proximal to the left subclavian artery origin and maintaining vessel patency through a side branch. We describe our experience with the Gore TBE device in 20 patients for acute indications, including blunt thoracic aortic injuries, complicated dissections, and ruptured aneurysms. Technical success, with exclusion of pathology and left subclavian patency, was 100% without major complications within 30 days. Our early Gore TBE device experience demonstrates safe use in acute aortic pathology without an increased risk of complications.

1 March 2021 in Seminars in Vascular Surgery
Verified
Journal Article
Closed access
KDKathryn L. DiLosa
Kathryn L. DiLosa
MHMisty Humphries
Misty Humphries